RESUMO
BACKGROUND: Limited research exists on laser treatment of giant congenital melanocytic nevus (GCMN). OBJECTIVE: We sought to elucidate the efficacy of the Erbium: YAG laser on GCMN and the histologic factors associated with a positive clinical response. METHODS AND MATERIALS: Between 2019 and 2022, we enrolled 30 medium-to-giant CMN patients who underwent Er: YAG laser treatment. All patients received biopsies before and after laser treatments. Clinical efficacy outcomes were evaluated by the investigator's global assessment (IGA), 5-point scale of depigmentation, and Vancouver Scar Scale (VSS) scores at least 6 months after treatment. RESULTS: Of the 30 cases, 18 (60.0%) showed improvement (IGA score ≥3). Eight (26.7%) patients showed repigmentation. Eight (26.7%) patients developed hypertrophic scars. The average IGA, depigmentation, and VSS scores were 2.93, 3.57, and 3.20. The IGA score was higher (3.24 ± 1.18 vs. 2.22 ± 0.97, p = 0.031) and a lower repigmentation rate (14.3% vs. 55.6%, p = 0.032) was observed in the cases with Grenz zone. The IGA score was higher (3.33 ± 1.24 vs. 2.13 ± 0.89, p = 0.023) and the repigmentation rate was lower (11.1% vs. 50.0%, p = 0.034) also in the cases with the melanocytes nests with aggregation of melanin. Lesions with superficial ablation resulted in less hypertrophic scar formation than those with deep ablation (5.9% vs. 53.8%, p < 0.05). CONCLUSION: The Er: YAG laser demonstrated effective clinical results for GCMNs. The grenz zone and the melanocytes nests with aggregation of melanin are promising predictors of laser efficacy.
Assuntos
Cicatriz Hipertrófica , Terapia a Laser , Lasers de Estado Sólido , Nevo Pigmentado , Neoplasias Cutâneas , Humanos , Érbio , Melaninas , Lasers de Estado Sólido/uso terapêutico , Terapia a Laser/métodos , Resultado do Tratamento , Nevo Pigmentado/radioterapia , Nevo Pigmentado/cirurgia , Cicatriz Hipertrófica/patologia , Imunoglobulina ARESUMO
Treatment of pigmented lesions is one of the major challenges of laser and cosmetic practitioners. The most common pigmented lesions that are treated by lasers are melanocytic nevi, ephelides, solar lentigines, and café au lait macules. Melanin absorbs different wavelengths (500-1100 nm); thereby, treatment of various pigmented lesions requires the application of lasers with different wavelengths. Choosing the most appropriate type of laser depends on various factors such as the chromophore and the location of a specific lesion in the skin. In this paper, we aim to review the most efficient laser treatment protocols for each pigmented skin lesion and compare their efficacy in each part based on the previous studies.
Assuntos
Terapia a Laser , Lentigo , Nevo Pigmentado , Neoplasias Cutâneas , Humanos , Terapia a Laser/métodos , Nevo Pigmentado/radioterapia , Nevo Pigmentado/cirurgia , Nevo Pigmentado/patologia , Neoplasias Cutâneas/radioterapia , Neoplasias Cutâneas/cirurgia , Neoplasias Cutâneas/patologia , LasersRESUMO
Hori nevus, also known as acquired bilateral nevus of Ota-like macules, is a form of dermal melanocytosis found most commonly in women of East Asian heritage. It presents as discrete brown macules on the bilateral cheeks which later coalesce into confluent grey-brown macules and small patches. Herein, we report a classic case of Hori nevus and discuss the histologic findings and differential diagnosis. We also review the proposed pathophysiology, genetic considerations, and treatment options.
Assuntos
Bochecha/patologia , Neoplasias Faciais/patologia , Nevo Pigmentado/patologia , Neoplasias Cutâneas/patologia , Adulto , Povo Asiático , Diagnóstico Diferencial , Neoplasias Faciais/etnologia , Neoplasias Faciais/radioterapia , Feminino , Humanos , Lasers de Estado Sólido/uso terapêutico , Nevo Pigmentado/etnologia , Nevo Pigmentado/radioterapia , Neoplasias Cutâneas/etnologia , Neoplasias Cutâneas/radioterapiaRESUMO
OBJECTIVES: For small to medium sized congenital melanocytic nevi (CMN), the treatment of choice is staged surgical excision. Ablative lasers or pigment-specific lasers have also been recommended for lesions difficult for surgical removal or to avoid surgery. In this study, we retrospectively analyzed the results of several treatment options for CMN to find out the optimal treatment method. METHODS: Patients with small to medium sized CMN were retrospectively reviewed. Treatment options were categorized into four groups: (i) Excision only; (ii) Excision followed by scar laser; (iii) Excision followed by pigment-specific laser; and (iv) Laser only. Treatment response was assessed by investigator's global assessment (IGA) score on a seven-point scale. RESULTS: A total of 119 cases were included. Lesions were most commonly located on the face (59/119, 49.6%), measured 2 â¼ 10 cm in size (72/119, 60.5%), and treated with excision only (50/119, 42.0%). Among treatment options, excision followed by scar laser showed the highest IGA score of 6.38. Options including surgical methods showed higher IGA scores compared to laser-only treatment (P < 0.01). Staged excisions and single excisions showed no difference in IGA scores. Patient satisfaction scores increased after scar laser treatment of the staged excision scar. CONCLUSIONS: For the treatment of small to medium sized CMN, treatment strategies including surgical methods are cosmetically superior to laser-only treatment. Also, the combination of surgical excision with scar laser has the potential for better clinical outcomes and patient satisfaction. Lasers Surg. Med. 51:62-67, 2019. © 2018 Wiley Periodicals, Inc.
Assuntos
Procedimentos Cirúrgicos Dermatológicos/métodos , Terapia a Laser/métodos , Nevo Pigmentado/radioterapia , Nevo Pigmentado/cirurgia , Adolescente , Adulto , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , República da Coreia , Estudos RetrospectivosRESUMO
Patients with large benign melanocytic lesions located on the neck represent a therapeutic challenge since the neck is a high-risk area for hypertrophic scarring and/or retraction. When treating a benign, extensive and visible melanocytic lesion, the choice of therapy mainly depends on the likelihood of improved cosmesis. We report a case of a 33-year-old woman with a medium-sized Nevus Spilus located on the neck, successfully treated with four sessions of pulsed dye laser. We achieved an excellent clinical and cosmetic result in such a challenging area. No scarring, distortion or significant dyscromia were observed after 24 months.
Assuntos
Lasers de Corante/uso terapêutico , Terapia com Luz de Baixa Intensidade , Nevo Pigmentado/radioterapia , Neoplasias Cutâneas/radioterapia , Adulto , Feminino , Humanos , PescoçoRESUMO
Laser therapy has become a routine procedure in dermatological practice and is frequently also used for pigmented lesions. Few reports exist of melanomas diagnosed in lesions previously treated by laser therapy. Between 2007 and 2014, we identified 11 patients who presented to our department with a melanoma diagnosed in a region previously treated by laser therapy. The course of events until the diagnosis of melanoma was assessed as well as patient outcome including treatment for disease progression. No histological assessment had been performed prior to laser therapy in nine of 11 (82%) cases. Benign melanocytic lesions had been diagnosed by biopsy prior to laser therapy in the other two cases. Time from laser therapy to diagnosis of melanoma ranged from less than 1 to 10 years. Stage of disease at diagnosis varied from stage IA to IIIC. Four patients progressed to stage IV disease, of whom at least one died of melanoma. We conclude that laser treatment of pigmented lesions can complicate the diagnosis of melanoma and lead to diagnosis delay with potentially fatal consequences. Considering this risk, we believe laser therapy for pigmented lesions should either be avoided entirely or at a minimum performed only after prior histological assessment.
Assuntos
Diagnóstico Tardio/prevenção & controle , Terapia a Laser/efeitos adversos , Melanoma/diagnóstico , Nevo Pigmentado/radioterapia , Neoplasias Cutâneas/diagnóstico , Adulto , Idoso , Biópsia , Neoplasias Encefálicas/secundário , Progressão da Doença , Evolução Fatal , Feminino , Humanos , Excisão de Linfonodo , Metástase Linfática , Imageamento por Ressonância Magnética , Masculino , Melanoma/patologia , Melanoma/cirurgia , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Nevo Pigmentado/patologia , Estudos Retrospectivos , Neoplasias Cutâneas/patologiaAssuntos
Lasers de Excimer/uso terapêutico , Terapia com Luz de Baixa Intensidade/métodos , Nevo Pigmentado/radioterapia , Neoplasias Cutâneas/radioterapia , Adolescente , Criança , Pré-Escolar , Feminino , Seguimentos , Humanos , Hipopigmentação/patologia , Hipopigmentação/radioterapia , Lactente , Masculino , Nevo Pigmentado/patologia , Estudos Retrospectivos , Estudos de Amostragem , Neoplasias Cutâneas/patologia , Resultado do Tratamento , Adulto JovemRESUMO
Total excision of congenital melanocytic nevi (CMN) is not always feasible. We here present our experience of using carbon dioxide laser and Q-switched neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser to treat nodular CMN of the nasal ala. Q-switched Nd:YAG laser and/or carbon dioxide laser were used to treat eight cases of nasal ala nodular CMN. Carbon dioxide laser was utilized to ablate all visible melanocytic tissue within one session. Ablation was performed so as to reproduce the original anatomical contours as closely as possible. Recurrences were treated in the same way. Q-switched Nd:YAG laser was also used to irradiate all target lesions to achieve the desired end point within one session. The intervals between treatments were at least 8 weeks. Recurrence of melanocytic tissue, scar formation, pigmentation, depigmentation, and the degree of patient satisfaction were recorded at every visit. Two of the eight patients were treated with Q-switched Nd:YAG laser. Although, the lesion lightened in one of them, the hyperplastic tissue persisted. Eventually, these two patients, along with the remaining six patients, were successfully treated with a carbon dioxide laser. We recommend carbon dioxide laser treatment for nodular nasal CMN. This simple treatment does not involve skin flap transplantation and has good cosmetic outcomes. Although Q-switched Nd:YAG laser does lighten some nasal nodular CMNs, it does not eradicate the hyperplastic tissue, and is therefore not an effective treatment for nodular nasal CMN.
Assuntos
Terapia a Laser , Lasers de Gás/uso terapêutico , Lasers de Estado Sólido/uso terapêutico , Nevo Pigmentado/congênito , Nevo Pigmentado/radioterapia , Nariz/patologia , Nariz/efeitos da radiação , Neoplasias Cutâneas/radioterapia , Adolescente , Criança , Cicatriz/patologia , Feminino , Humanos , Terapia a Laser/efeitos adversos , Masculino , Satisfação do Paciente , Neoplasias Cutâneas/congênito , Resultado do Tratamento , Adulto JovemRESUMO
BACKGROUND: Acquired melanocytic nevi (AMN) have been reported to undergo morphological and dermoscopic changes following exposure to narrow-band ultraviolet B (NB-UVB) radiation. OBJECTIVE: To study the morphological, dermoscopic and immunohistochemical changes in AMN following NB-UVB radiation. METHODS: Suberythemogenic NB-UVB sessions were delivered to 40 patients with AMN. For each patient, a minimum of 2 nevi were selected. One nevus was surgically removed from each patient prior to sessions as control; for the other nevus, dermoscopic images were captured before and after NB-UVB sessions. The images were evaluated for changes. At the end, another nevus was surgically removed for immunohistochemical assessment of Ki-67 and melan-A. RESULTS: Our study showed a statistically significant increase in the size of AMN following NB-UVB radiation. Benign dermoscopic changes were observed. Statistically significant positive correlations were found between some dermoscopic findings and the total cumulative dose of NB-UVB. Immunohistochemical analysis did not show any significant change in the exposed AMN. CONCLUSION: AMN irradiated with repeated suberythemogenic doses of NB-UVB showed benign morphological and dermoscopic changes, and this was confirmed by our immunohistochemical study.
Assuntos
Dermoscopia/métodos , Imuno-Histoquímica/métodos , Antígeno Ki-67/metabolismo , Antígeno MART-1/metabolismo , Nevo Pigmentado/diagnóstico , Neoplasias Cutâneas/diagnóstico , Terapia Ultravioleta/métodos , Adulto , Relação Dose-Resposta à Radiação , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nevo Pigmentado/metabolismo , Nevo Pigmentado/radioterapia , Índice de Gravidade de Doença , Pele/patologia , Neoplasias Cutâneas/metabolismo , Neoplasias Cutâneas/radioterapiaRESUMO
Congenital melanocytic nevi (CMN) are benign nevomelanocytic proliferations that are present at birth. CMN are commonly classified according to their size and the management of CMN is diverse, including excision, dermabrasion and laser treatment. Several studies have shown the effectiveness of laser therapy for CMN in cosmetically sensitive and anatomically critical areas. In the present case, combination treatment with intense pulsed light (IPL) and erbium:yttrium-aluminum-garnet (Er:YAG) laser was used, and its effectiveness was evaluated. A 56-year-old man with a CMN on the left malar area was treated with combined IPL and Er:YAG laser treatment once monthly. After ten sessions of treatment, the lesion showed improvement leaving only a grayish hue. Thus, we report a case of CMN on face that was successfully treated with combined IPL and Er:YAG laser treatment.
Assuntos
Lasers de Estado Sólido/uso terapêutico , Terapia com Luz de Baixa Intensidade/métodos , Nevo Pigmentado/radioterapia , Técnicas Cosméticas/instrumentação , Humanos , Terapia com Luz de Baixa Intensidade/instrumentação , Masculino , Pessoa de Meia-IdadeRESUMO
We report a case of large histopathologically proven melanocytoma of the ciliary body in a 15-year-old male, presented with rapid extraocular growth following incisional biopsy with scleral patch graft. We chose brachytherapy with Ruthenium 106 plaque over enucleation as the later was refused by the parents. The initial apical height of the tumor was 14.2 mm on ultrasonography. Two weeks after brachytherapy, the mass regressed to a size of 8.1 mm and 1 year later to 6.7 mm. This is the first case report showing the response of brachytherapy to ciliary body melanocytoma, which results in ocular and visual acuity salvation with considerable decreased in size of the tumor. The authors conclude that brachytherapy is an option in the management of non-resectable melanocytoma of the ciliary body.
Assuntos
Braquiterapia/métodos , Corpo Ciliar , Nevo Pigmentado/radioterapia , Neoplasias Uveais/radioterapia , Adolescente , Biópsia por Agulha Fina , Seguimentos , Humanos , Imageamento por Ressonância Magnética , Masculino , Nevo Pigmentado/patologia , Terapia de Salvação , Neoplasias Uveais/patologia , Acuidade VisualRESUMO
BACKGROUND: The aim of this retrospective report is to describe our experience with the Essen-23G biopsy forceps (Akgül forceps) for biopsies of pigmented iris tumours. METHODS: In this retrospective study of cases between October 2012 and September 2013, patients with iris tumours and clinical signs for malignancy underwent biopsy to secure the diagnosis. The Essen-23G-forceps was used to grasp and extract tissue through a clear corneal incision. Eventual entry and bimanual manipulation with a 23G mini-scissors was achieved through a second incision. Tissue samples were fixed in a sterile tube for further histopathological and immunohistochemical evaluation. RESULTS: Seven eyes of seven patients underwent biopsy using the forceps. The average thickness of the iris tumours was 1.07±0.79â mm. A second corneal incision for scissoring in a bimanual technique was necessary in 5 cases (71%). In 6 cases (85%), a precise histological and immunohistochemical diagnosis was achieved. Complications were limited to minute bleeding at the biopsy site and one case of relative pupil enlargement (anisocoria) without further refractive issues. CONCLUSIONS: Iris tumour biopsies can be successfully approached using a cavernous 23G intraocular forceps with a low risk for procedure-related complications. The conical interior design allows for removal of whole tissue pieces with minimal manipulative artefacts. An optional bimanual access through a second corneal incision and use of a 23G scissors provides better efficacy.
Assuntos
Neoplasias da Íris/patologia , Melanoma/patologia , Nevo Pigmentado/patologia , Procedimentos Cirúrgicos Oftalmológicos/instrumentação , Adulto , Idoso , Biomarcadores Tumorais/metabolismo , Biópsia/instrumentação , Feminino , Humanos , Neoplasias da Íris/metabolismo , Neoplasias da Íris/radioterapia , Masculino , Melanoma/metabolismo , Melanoma/radioterapia , Microcirurgia , Pessoa de Meia-Idade , Nevo Pigmentado/metabolismo , Nevo Pigmentado/radioterapia , Terapia com Prótons , Estudos RetrospectivosRESUMO
The incidence of cutaneous malignant melanoma is increasing at a greater rate than that of any other cancer in the world. However, an effective therapy for malignant melanoma has not been established. Recently, some studies have shown an antitumor effect of non-equilibrium atmospheric pressure plasmas (NEAPPs) in vitro. Here, we examined the in vivo effect of NEAPP on cell cycle regulators, key elements for malignant transformation, in spontaneously developed benign melanocytic tumors in a hairless animal model. NEAPP irradiation decreased expression levels of cell cycle promoters, Cyclin D1, E1 and E2, and increased expression level of a cell cycle repressor, p27(KIP) (1) . Cyclin D1, E1 and E2 and p27(KIP) expression levels were associated with malignant transformation of the benign tumor in the animal model. Our results suggest that NEAPP irradiation suppresses malignant transformation of a benign melanocytic tumor via control of the expression levels of cell cycle regulators.
Assuntos
Argônio/uso terapêutico , Proteínas de Ciclo Celular/genética , Regulação Neoplásica da Expressão Gênica/efeitos da radiação , Nevo Pigmentado/genética , Proteínas Proto-Oncogênicas c-ret/genética , Radioterapia/métodos , Neoplasias Cutâneas/genética , Animais , Pressão Atmosférica , Ciclo Celular/genética , Ciclo Celular/efeitos da radiação , Proteínas de Ciclo Celular/efeitos da radiação , Transformação Celular Neoplásica/genética , Transformação Celular Neoplásica/efeitos da radiação , Modelos Animais de Doenças , Progressão da Doença , Regulação Neoplásica da Expressão Gênica/genética , Camundongos , Camundongos Pelados , Camundongos Transgênicos , Nevo Pigmentado/patologia , Nevo Pigmentado/radioterapia , Neoplasias Cutâneas/prevenção & controle , Neoplasias Cutâneas/radioterapiaRESUMO
Choroidal melanoma may arise de novo or transformed from a previously existing nevus. Modern cytogenetical techniques allow us to determine and classify the genetic aberrations of such tumors. We report a case of a 55-year-old man presenting a malignant transformation of a previously known choroidal nevus in his right eye. Nine years earlier, that same eye was treated with brachytherapy for a malignant melanoma. Enucleation was indicated followed by histopathological study as well as gene mutation analysis of the tumor cells. The second melanoma was anatomically independent from the first one, discarding the possibility of spreading. Cytogenetical study resulted in significant loss of the short arm of chromosome 1 and the long arm of chromosome 3. Only 21 cases of multiple uveal melanoma in the same eye are reported in the literature. To our knowledge this is the first cytogenetical report of one of such cases. It highlights the importance of follow-up in these patients, especially when risk factors like a choroidal naevus are present.
Assuntos
Transformação Celular Neoplásica , Neoplasias da Coroide/patologia , Melanoma/genética , Neoplasias Primárias Múltiplas/genética , Nevo Pigmentado/patologia , Neoplasias Uveais/genética , Braquiterapia , Neoplasias da Coroide/radioterapia , Cromossomos Humanos Par 1/genética , Cromossomos Humanos Par 3/genética , DNA de Neoplasias/genética , Enucleação Ocular , Humanos , Masculino , Melanoma/patologia , Repetições de Microssatélites/genética , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase Multiplex , Neoplasias Primárias Múltiplas/patologia , Nevo Pigmentado/radioterapia , Neoplasias Uveais/patologiaRESUMO
BACKGROUND: Melanocytic naevi have been observed to undergo morphological changes following exposure to narrowband ultraviolet (NB-UV)B radiation. OBJECTIVES: To analyse changes in naevi exposed to NB-UVB in a large cohort of patients. METHODS: Subjects referred for phototherapy had macroscopic and dermoscopic images taken of prominent melanocytic naevi at the following time points: immediately prior to NB-UVB treatment, after 10 exposures, after 30 exposures or at the end of treatment if earlier, and 3 months after discontinuing treatment. Four dermatologists, by consensus, examined each naevus for specific clinical and dermoscopic features at each time point. The size (area) of each naevus was determined by plenimetry. RESULTS: Complete sets of images were taken for 36 out of 51 patients. The most common global dermoscopic patterns in the 440 naevi examined were reticular (50%) and globular (32%). Following NB-UVB exposure, blurring or merging of lines was observed in 45% of reticular naevi. An increase in colour intensity and in the number of dots or globules was observed in 63% of globular naevi, and 167 naevi (40%) underwent a change in size. Of these, 91/167 (54%) decreased in size, with a median area reduction of 8% (0·9-42%); while 76/167 (46%) increased in size, with a median area increase of 9% (1-76%). CONCLUSIONS: Around half of naevi exposed to a course of NB-UVB treatment undergo size or morphological changes. Naevi that enlarged tended to revert to pretreatment size 3 months after discontinuation of phototherapy.
Assuntos
Nevo Pigmentado/radioterapia , Neoplasias Cutâneas/radioterapia , Terapia Ultravioleta/métodos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Dermoscopia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nevo Pigmentado/patologia , Resultado do Tratamento , Carga Tumoral , Adulto JovemAssuntos
Braquiterapia/efeitos adversos , Perda de Células Endoteliais da Córnea/etiologia , Endotélio Corneano/efeitos da radiação , Neoplasias da Íris/radioterapia , Melanoma/radioterapia , Lesões por Radiação/etiologia , Radioisótopos de Rutênio/efeitos adversos , Adulto , Idoso , Idoso de 80 Anos ou mais , Contagem de Células , Perda de Células Endoteliais da Córnea/diagnóstico , Endotélio Corneano/patologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nevo Pigmentado/radioterapia , Facoemulsificação/efeitos adversos , Lesões por Radiação/diagnóstico , Radioisótopos de Rutênio/uso terapêutico , Adulto JovemRESUMO
A 62-year-old woman was referred for a pituitary tumour diagnosed because of a chronic asthenia and visual disorders. Cerebral MRI showed a pituitary tumour compressing the optic chiasm and enhanced after gadolinium injection. Biological findings showed panhypopituitarism and hyperprolactinemia. The diagnostic of pituitary macro-adenoma was performed and the patient was treated with hormone replacement therapy and dopaminergic agonist. Six months later, she presented visual disorders worsening leading to surgical excision. The diagnosis of pituitary melanocytoma was performed after anatomo-clinical confrontation. Post-operative radiation was done.
Assuntos
Erros de Diagnóstico , Nevo Pigmentado/patologia , Neoplasias Hipofisárias/patologia , Adenoma/diagnóstico , Terapia Combinada , Diagnóstico Tardio , Agonistas de Dopamina/uso terapêutico , Feminino , Terapia de Reposição Hormonal , Humanos , Hiperprolactinemia/etiologia , Hipofisectomia , Hipopituitarismo/etiologia , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Síndromes de Compressão Nervosa/etiologia , Nevo Pigmentado/complicações , Nevo Pigmentado/diagnóstico , Nevo Pigmentado/radioterapia , Nevo Pigmentado/cirurgia , Quiasma Óptico/patologia , Hormônios Adeno-Hipofisários/uso terapêutico , Neoplasias Hipofisárias/complicações , Neoplasias Hipofisárias/diagnóstico , Neoplasias Hipofisárias/tratamento farmacológico , Neoplasias Hipofisárias/radioterapia , Neoplasias Hipofisárias/cirurgia , Radioterapia Adjuvante , Reoperação , Transtornos da Visão/etiologiaRESUMO
PURPOSE: To report sequential bilateral uveal melanoma in an arc welder. METHODS: Case report. RESULTS: A 57-year-old Caucasian male, with a 15-year profession of arc welding, was found to have an iridociliary mass in his left eye (OS), measuring 14 × 10 × 4 mm, and proven on fine needle aspiration biopsy to be spindle B-cell melanoma. A coincidental small choroidal nevus was observed in the right eye (OD). There was no ocular melanocytosis. Plaque radiotherapy was applied OS, with regression of the iridociliary melanoma. Four years later, the choroidal nevus OD enlarged into melanoma measuring 8 × 7 × 2.7 mm and was treated successfully with plaque radiotherapy. There was no evidence of systemic metastasis at 56-month follow-up. CONCLUSION: Arc welding is a known environmental risk for unilateral uveal melanoma, and possibly predisposed our patient to bilateral uveal melanoma.
Assuntos
Neoplasias da Coroide/patologia , Melanoma/patologia , Neoplasias Induzidas por Radiação/patologia , Nevo Pigmentado/patologia , Doenças Profissionais/etiologia , Soldagem , Biópsia por Agulha , Braquiterapia , Neoplasias da Coroide/diagnóstico por imagem , Neoplasias da Coroide/radioterapia , Lateralidade Funcional , Humanos , Radioisótopos do Iodo/uso terapêutico , Masculino , Melanoma/diagnóstico por imagem , Melanoma/radioterapia , Pessoa de Meia-Idade , Neoplasias Induzidas por Radiação/diagnóstico por imagem , Neoplasias Induzidas por Radiação/radioterapia , Nevo Pigmentado/diagnóstico por imagem , Nevo Pigmentado/radioterapia , UltrassonografiaRESUMO
The growing diversification of the patient population coupled with the increasing demand for cosmetic laser rejuvenation has highlighted the need to develop cutaneous laser systems and establish treatment protocols for patients with a wide range of skin conditions and phototypes. Recent technologic advancements have provided viable treatment options to achieve clinical outcomes that were previously only attainable in patients with lighter skin tones. This review provides an updated discussion of the range of laser treatments available for pigmented skin and sets the stage for further advancements. Pigment-specific laser technology with green, red, or near-infrared light targets a variety of pigmented lesions such as lentigines, ephelides, café-au-lait macules, and melanocytic nevi as well as tattoos and unwanted hair. Short-pulsed alexandrite, ruby, and neodymium:yttrium-aluminum-garnet (Nd:YAG) lasers are used for pigmented lesions and tattoos, whereas their longer pulse-width laser counterparts are used for laser-assisted hair removal. Vascular lesions and hypertrophic scars can be treated with a variety of vascular-specific lasers, but it is the pulsed dye laser (PDL) that has long been the gold standard treatment for these lesions due to its high specificity for hemoglobin and its ability to improve skin surface texture in children and adults. Laser skin resurfacing techniques for photodamaged skin and atrophic scars have been optimized with fractional technology to produce excellent clinical outcomes and minimal complication risks. Radiofrequency and nonablative lasers are also used to provide skin tightening and collagen remodeling with virtually no postoperative recovery.
Assuntos
Terapia a Laser , Dermatopatias/radioterapia , Pigmentação da Pele , Adulto , Manchas Café com Leite/radioterapia , Criança , Cicatriz Hipertrófica/radioterapia , Remoção de Cabelo , Hemangioma/radioterapia , Humanos , Queloide/radioterapia , Lasers , Lentigo/radioterapia , Melanose/radioterapia , Neoplasias de Tecido Vascular/radioterapia , Nevo Pigmentado/radioterapia , Mancha Vinho do Porto/radioterapia , Neoplasias Cutâneas/radioterapia , Tatuagem , Telangiectasia/radioterapiaRESUMO
OBJECTIVE: To evaluate the risk of dying of metastatic choroidal melanoma in patients with small, indeterminate, pigmented lesions of the uveal tract. METHODS: A cohort of 1063 consecutive patients were evaluated in the Ocular Oncology Clinic of the Massachusetts Eye and Ear Infirmary between January 1976 and June 1996 with definite choroidal nevus (n = 256), indeterminate lesions (n = 334), or small melanoma (n = 373). Deaths occurring up to December 1998 were identified through active follow-up or by a search of the National Death Index. Cumulative death rates were compared among diagnostic groups using the Kaplan-Meier method. RESULTS: Mean lesion diameter was 4.6 mm in the nevi, 7.0 mm in the indeterminate lesions, and 8.1 mm in the small melanomas. Patients ranged in age from 3 to 95 years (median, 64 years). A total of 15 deaths due to ocular melanoma were ascertained (median follow-up of survivors, 8.2 years), 13 in the melanoma group and 2 in the indeterminate lesion group; actuarial tumor-specific death rates at 10 years after evaluation were 5% (95% confidence interval, 3%-8%) and 1% (95% confidence interval 0%-3%), respectively. No deaths due to ocular melanoma occurred in the nevus group. CONCLUSIONS: These data document the very low malignant potential of most indeterminate melanocytic lesions of the choroid and support the current practice of monitoring these tumors, with treatment provided when growth and other signs of malignant transformation are observed.